ferrous fumarate 322 MG Oral Tablet

Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.

Start free with Eleplan

Clinical drug

ferrous fumarate 322 MG Oral Tablet

322 MG · Oral Tablet · oral

A form of ferrous →

ferrous fumarate 322 MG Oral Tablet. Strength, form, class, interactions & more.

ferrous fumarate 322 MG Oral Tablet

Active ingredient

Drug interactions

The label outlines various drug interactions with combined oral contraceptives (COCs) that may affect their efficacy and plasma concentrations.

  • majorCYP3A4 inducers — may decrease the effectiveness of COCs or increase breakthrough bleeding
  • majorphenytoin — may decrease the effectiveness of COCs
  • majorbarbiturates — may decrease the effectiveness of COCs
  • majorcarbamazepine — may decrease the effectiveness of COCs
  • majorbosentan — may decrease the effectiveness of COCs
  • majorfelbamate — may decrease the effectiveness of COCs
  • majorgriseofulvin — may decrease the effectiveness of COCs
  • majoroxcarbazepine — may decrease the effectiveness of COCs
  • majorrifampicin — may decrease the effectiveness of COCs
  • majortopiramate — may decrease the effectiveness of COCs
  • majorrifabutin — may decrease the effectiveness of COCs
  • majorrufinamide — may decrease the effectiveness of COCs
  • majoraprepitant — may decrease the effectiveness of COCs
  • majorSt. John’s wort — may decrease the effectiveness of COCs
  • majorcolesevelam — significantly decreases the AUC of EE
  • moderateatorvastatin — increases AUC values for EE
  • moderaterosuvastatin — increases AUC values for EE
  • moderateascorbic acid — may increase plasma EE concentrations
  • moderateacetaminophen — may increase plasma EE concentrations
  • moderateCYP3A4 inhibitors — may increase plasma hormone concentrations
  • moderateHIV protease inhibitors — significant changes in plasma concentrations of estrogen and/or progestin
  • moderateHCV protease inhibitors — significant changes in plasma concentrations of estrogen and/or progestin
  • majorlamotrigine — may reduce seizure control
  • moderatethyroid hormone — may need increased doses of thyroid hormone
  • majorombitasvir/paritaprevir/ritonavir — potential for ALT elevations

Source: RxNorm + openFDA + RxClass + FAERS · 2026

Look up another medication

Powered by Eleplan

A drug lookup is just the start. Eleplan keeps the whole care plan in one place.

Medications, diagnoses, documents, appointments, and the whole care team — organized and always in sync, with Ellie, your AI care assistant, on top of it. Free to start.